Why not Mindray becoming the king of Chinese medical equipment?
The king of medical equipment will only be produced on high-value medical consumables. Mindray is excellent, but his track is not as good as ToC's high-value medical consumables. Mindray’s equipment ToB is only bought by the hospital, purchased at a time, and used for many years. Mindray is excellent, but his track is not as good as ToC's high-value medical consumables. Mindray’s equipment ToB is only bought by the hospital, purchased at a time, and used for many years.
Mindray's target should be the medical department of GE or Siemens. The benchmarking company of MicroPort is Medtronic.
The two benchmark companies are not at the same level. GE's market value is only 100 billion US dollars, and medical equipment is only part of it. Medtronic has a market value of US$150 billion, all of which are high-value medical consumables.
Minimally Invasive Medical has a layout on almost all major subdivisions of high-value medical consumables, either the first or the only one (orthopedics is an exception, but there is a chance to reverse). From European and American experience, it is difficult for a single track to produce a Medtronic-level king. Only minimally invasive medical care has layouts in multiple major subdivision tracks.
Although minimally invasive medicine is still in the teenage years, there is huge room for imagination This is determined by the characteristics of high-value medical consumables. The high-value medical consumables industry represented by the cardiovascular business is an industry driven by technology. Often the emergence of a new technology can open up a segment of the market, but the space for a single market is often limited. Therefore, when the industry becomes mature, maintaining a certain market share through related diversification and mergers and acquisitions has become the only choice for medical device companies to maintain their competitive advantages. The representative company is Medtronic.
In fiscal year 2019, Medtronic had revenues of US$30.5 billion and a market value of US$150 billion. Its business has four major sectors, but the cardiovascular business is the most important.
Minimally Invasive Medical has almost completed the first 40 years of Medtronic in 20 years. The layout has been completed. With a core product and a series of blockbuster products that have just been launched, it needs continuous development to reach adulthood.
The layout of Minimally Invasive corresponds to Medtronic (products of cardiovascular, orthopedics, etc., annual sales of 30.5 billion US dollars, market value of 150 billion US dollars) + Intuitive Surgery Company (product robots, annual sales of 5 billion US dollars, market value of 71.1 billion US dollars), preliminary Formed the appearance of a benchmark giant.
Mindray owns China's medical equipment today, and its current market value is approaching 500 billion. It will continue to be excellent, and it will even continue to advance by leaps and bounds for a long time, and continue to create considerable revenue and profits.
Minimally Invasive Medical has the future of China's medical equipment. Although the current market value is less than 100 billion, Xinmai surpasses LifeTech and becomes the first, Xintong surpasses Qiming to become the first, Minimally Invasive robot domestically made first, and neural intervention ( Shentong) No. 1 in domestic production (all domestic rivals have an order of magnitude smaller than Shentong's revenue), and No. 1 in China in heart rhythm.
MicroPort has achieved the No. 1 domestically in almost all frontier fields. The appearance of the king is undoubtedly revealed.
Surgaid Medical (Xiamen) Co., Ltd
Surgaid Medical (Xiamen) Co., Ltd has been committed to surgical product development ,production and marketing for 10 more years . In particular, minimally invasive surgical products. Minimally invasive surgery is a surgical direction of development. Such as Disposable Laparoscopic Trocar, Linear Cutter Stapler, Circular Stapler, PPH, and so on.
Manufacturing our own Surgical products allows us to have complete control over the design and evolution of our products. We are able to adapt quickly to the constantly evolving healthcare market and offer high quality, single-use, cost-effective solutions that directly compete with global market-leaders.
Surgaid products:
For more product information at https://www.surgaid-medical.com
